Harlow startup Pharmaceutech Ltd raises £20k for addiction management AI

AI-driven medical devices and innovations are the core focus of Harlow-based Pharmaceutech Ltd. The company produces software, including its OpiBud platform for real-time monitoring, to transform healthcare and improve quality of life. Its solutions target a range of stakeholders including patients, families, caregivers, and clinicians for addiction management, while providing data to healthcare organizations and investors.

A recent funding round has brought an estimated £20k into the business. This capital injection results in an estimated post-money valuation of £620k.

The firm was incorporated in 2023. Its most recent financial accounts cover the period ending 30 April 2025 (the share allotment was filed in July).